Hematologic Toxicity Associated with Interferon-Based Hepatitis C Therapy in HIV Type 1-Coinfected Subjects | Zendy

Caroline Behler | Zendy; Eric Vittinghoff | Zendy; Feng Lin | Zendy; Raymond T. Chung | Zendy; Marion G. Peters | Zendy; Gregory K. Robbins | Zendy; Paul A. Volberding | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hematologic Toxicity Associated with Interferon-Based Hepatitis C Therapy in HIV Type 1-Coinfected Subjects

Author(s) -

Caroline Behler,

Eric Vittinghoff,

Feng Lin,

Raymond T. Chung,

Marion G. Peters,

Gregory K. Robbins,

Paul A. Volberding

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/515398

Subject(s) - medicine , hepatitis c , toxicity , interferon , virology , immunology , interferon alfa , human immunodeficiency virus (hiv) , viral disease

This study investigates whether dose modifications for adverse hematologic effects or the use of hematopoietic growth factors influenced the outcome of therapy for hepatitis C virus (HCV) infection in patients who were coinfected with HCV and human immunodeficiency virus (HIV) and who were participants in a randomized, controlled trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research